The diagnostic accuracy of the age‐adjusted and prostate volume‐adjusted biopsy method in males with prostate specific antigen levels of 4.1–10.0 ng/mL

The authors evaluated a new age‐adjusted and prostate volume‐adjusted biopsy method for the detection of prostate carcinoma through the transperineal and the transrectal approaches in men with PSA levels of 4.1–10.0 ng/mL.

[1]  K Ito,et al.  Clinicopathological Features of Prostate Cancer Detected by Transrectal Ultrasonography‐Guided Systematic Six‐Sextant Biopsy , 1997, International journal of urology.

[2]  T. Stamey,et al.  Positive prostate biopsy rate consistently increases with age at the same prostate-specific antigen level in patients with normal digital rectal examination. , 1998, Urology.

[3]  C. Amling,et al.  Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. , 2000, The Journal of urology.

[4]  J. Melamed,et al.  Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. , 1998, The Journal of urology.

[5]  W. Catalona,et al.  Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.

[6]  D L McCullough,et al.  Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. , 1997, The Journal of urology.

[7]  W. Catalona,et al.  Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.

[8]  L. Bégin,et al.  Value of systematic transition zone biopsies in the early detection of prostate cancer. , 1996, The Journal of urology.

[9]  C. Roehrborn,et al.  Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. , 1996, Urology.

[10]  H. Huland,et al.  Systematic sextant biopsies in 651 patients referred for prostate evaluation. , 1994, The Journal of urology.

[11]  J Drago,et al.  The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men , 1991, Cancer.

[12]  W. Catalona.  Re: Serum Prostate Specific Antigen as Pre-Screening Test for Prostate Cancer, by F. Labrie, A. Dupont, R. Suburu, L. Cusan, M. Tremblay, J.-L. Gomez and J. Emond, J. Urol., 147: 846–852, 1992 , 1993 .

[13]  J. Epstein,et al.  Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy , 1999 .

[14]  P. Walsh.  The definition and preoperative prediction of clinically insignificant prostate cancer. , 1996, The Journal of urology.

[15]  J. Oesterling,et al.  A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. , 1998, The Journal of urology.

[16]  D. Johnston,et al.  A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. , 2000, The Journal of urology.

[17]  K. Shinohara,et al.  Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. , 1998, The Journal of urology.

[18]  T. Stamey,et al.  Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant. , 1998, Urology.

[19]  T. Stamey,et al.  PATTERNS OF PROGRESSION IN PROSTATE CANCER , 1986, The Lancet.

[20]  S. Bigler,et al.  Results of transition zone biopsy in black and white men with suspected prostate cancer. , 1999, Urology.

[21]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[22]  W. Fair,et al.  Indications for transition zone biopsy in the detection of prostatic carcinoma. , 1997, The Journal of urology.

[23]  W. Catalona,et al.  Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. , 1995, The Journal of urology.

[24]  W. Ellis,et al.  Repeat prostate needle biopsy: who needs it? , 1995, The Journal of urology.

[25]  K. Shinohara,et al.  Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection. , 1998, Urology.

[26]  W. Fair,et al.  Incidence and clinical significance of false-negative sextant prostate biopsies. , 1998, The Journal of urology.

[27]  T. H. van der Kwast,et al.  Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy. , 2000, Urology.

[28]  B. Djavan,et al.  Is One Set of Sextant Biopsies Enough to Rule Out Prostate Cancer? Influence of Transition and Total Prostate Volumes on Prostate Cancer Yield , 2000, European Urology.

[29]  John T. Wei,et al.  The influence of prostate size on cancer detection. , 1995, Urology.

[30]  Kazuto Ito,et al.  THE PRESENT STATUS, PROBLEMS, AND FUTURE OF MASS SCREENING FOR PROSTATE CANCER IN GUNMA PREFECTURE , 1999 .

[31]  J. Goméz,et al.  Serum prostate specific antigen as pre-screening test for prostate cancer. , 1992, The Journal of urology.

[32]  R. Vessella,et al.  Screening for prostatic carcinoma with prostate specific antigen. , 1992, The Journal of urology.

[33]  P. Walsh,et al.  The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. , 1999, The Journal of urology.

[34]  T. Stamey,et al.  Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume , 1993, Cancer.

[35]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.